Site 24: Yale University — New Haven, Connecticut

Site 24: Yale University is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 24: Yale University has participated in 1 clinical trials.

Therapeutic areas: Myasthenia Gravis, Generalized.

Sponsors: Ra Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 24: Yale University?

Site 24: Yale University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 24: Yale University conducted?

Site 24: Yale University has 1 clinical trials on record. Their work covers Myasthenia Gravis, Generalized.

Is Site 24: Yale University accredited by Crixeo Health?

Site 24: Yale University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 24: Yale University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.